Depression: a long-term illness and its treatment

Area of Science:

• Psychiatry
• Pharmacology

Background:

• Depression is a common, chronic, and recurring illness causing significant disability.
• Treatment strategies must address the long-term course and recurrence risk of depression.
• Adequate duration and dosage of antidepressant therapy are crucial for managing depression.

Purpose of the Study:

• To evaluate the long-term efficacy of antidepressants in preventing new episodes of depression (prophylaxis).
• To review evidence for antidepressants reducing the risk of depression recurrence.

Main Methods:

• Studies specifically designed to test prophylaxis in patients who responded to initial treatment and maintained response.
• Review of clinical trial data for specific antidepressants like imipramine, fluoxetine, and fluvoxamine.

Main Results:

• Long-term treatment with imipramine and fluoxetine demonstrated efficacy in reducing new depression episodes.
• Fluvoxamine showed effectiveness in a 1-year prophylactic study for patients with responded acute depression.
• Antidepressants were shown to reduce the risk of new depressive episodes.

Conclusions:

• Antidepressant prophylaxis is effective in reducing the risk of new depression episodes.
• Long-term continuation of antidepressant treatment is recommended to mitigate persistent risk.
• Evidence supports the use of specific antidepressants for the long-term management of recurrent depression.